7.990USD-2.68%Mkt Cap: 293.32M USDP/E: —Last update: 2026-06-01
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its produc…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap293.32M USD
Enterprise Value666.48M USD
Revenue (TTM)5.20M USD
Gross Profit-10.52M USD
Net Income (TTM)-173.80M USD
Revenue/Share0.1430 USD
Last Price7.990 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees61
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS04216R1023
Valuation
P/E (Trailing)—
P/E (Forward)-4.26
PEG—
EV/EBITDA-22.07
EV/Revenue128.12
P/S57.66
P/B-0.96
EPS (TTM)-7.78
EPS (Forward)-1.57
52W Range
1.74043% of range16.34
52W High16.34 USD
52W Low1.740 USD
Profitability
Gross Margin-202.13%
Oper. Margin-1113.44%
EBITDA Margin0.00%
Profit Margin0.00%
ROE79.51%
ROA-226.06%
Growth
Revenue Growth60.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.76M USD
CapEx (TTM)542.00K USD
FCF Margin-502.48%
FCF Yield-8.91%
Net Debt368.92M USD
Net Debt/EBITDA-12.21
Balance Sheet
Debt/Equity-1.32
Current Ratio0.64
Quick Ratio0.52
Book Value/Sh-8.5030 USD
Cash/Share0.1300 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMay 10, 2019
Splits
Last Split1:14
Split DateMay 10, 2019
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)17.50 USD
Target Range15.00 USD – 20.00 USD
# Analysts2
Ownership
Shares Out.36.71M
Float11.32M
Insiders68.53%
Institutions10.45%
Short Interest
Short Ratio3.0d
Short % Float2.09%
Short % Out.0.61%
Shares Short225.03K
Short (prev mo.)244.31K
Technical
SMA 509.894 (-19.2%)
SMA 2006.848 (+16.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)82.53K
Avg Vol (10d)81.72K
Technical Indicators
RSI (14)42.7
MACD-0.6178
MACD Signal-0.6499
MACD Hist.+0.0321
BB Upper9.651 USD
BB Middle8.532 USD
BB Lower7.413 USD
BB Width26.23%
ATR (14)1.063 USD
Vol Ratio (20d)1.01x